Dow Down0.08% Nasdaq Down0.35%

More On COT.V



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Critical Outcome Technologies Inc. (COT.V)

0.30 Down 0.02(4.76%) 2:07PM EST
ProfileGet Profile for:
Critical Outcome Technologies Inc.
700 Collip Circle
Suite 213
London, ON N6G 4X8
Canada - Map
Phone: 519-858-5157
Fax: 519-858-5179

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

Critical Outcome Technologies Inc., a biopharmaceutical company, engages in the development of treatment for cancer through targeted therapeutics in Canada. Its artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds from disease specific drug discovery through chemical optimization and preclinical testing. The company's lead compound, COTI-2, has a novel p53-dependent mechanism of action with selective and potent anti-cancer activity. Critical Outcome Technologies is developing COTI-2 for gynecologic cancers, including ovarian, cervical, and endometrial. The company is developing drug candidates for the treatment of acute myelogenous leukemia, colorectal cancer, small cell lung cancer, multiple sclerosis, Alzheimer’s disease, and HIV. Critical Outcome Technologies Inc. was founded in 1999 and is based in London, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Critical Outcome Technologies Inc.

Key Executives 
Dr. Wayne R. Danter M.D., FRCPC,
Co-Founder, Chief Exec. Officer, Pres, Chief Scientific Officer, Non-Independent Director and Chairman of Scientific Advisory Committee
Mr. Eugene Francis Kelly ,
Chief Financial Officer
Dr. Kowthar Salim MBA, Ph.D.,
Program Director and Sr. Scientist
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.